Jeffrey S. Ginsberg, MD - Hematology

Dr. Jeffrey Ginsberg reviews content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Ginsberg is a Professor in the Department of Medicine at McMaster University in Hamilton, Ontario. He has received many prestigious career support awards from the Heart and Stroke Foundation of Ontario (Research Fellowship for three years, Research Scholarship for 5 years, and Career Investigator for 15 years), Canadian Institute of Health Research (CIHR/Industry Chair for 10 years), and most recently an Endowed Chair, The David Braley and Nancy Gordon Chair for the investigation of thromboembolic diseases. He has been the director of the Thromboembolism Unit at Chedoke-McMaster Hospitals since 1989. In 1998 Dr. Ginsberg received the Stephen Garnett Distinction Award for Outstanding Physician which was awarded by the Hamilton Health Sciences Medical Staff.

Dr. Ginsberg is actively involved in research and has held over 50 peer-reviewed grants worth over $25 million dollars. He is an accomplished author, editing 4 books, over 250 peer-reviewed publications, scores of book chapters, and abstracts. His current research interests include the diagnosis of venous thrombosis and pulmonary embolism, clinical development of novel antithrombotic agents, the diagnosis and management of thrombosis during pregnancy, the presentation and treatment of post-thrombotic syndrome, and the investigation of the clinical complications of antiphospholipid antibodies.

Dr. Ginsberg has chaired and spoken at many prestigious meetings including ASH, AHA, ACCP, ACP and the FCCP. He was Editor-in-chief of the journal "Thrombosis Research". He is a regular grant reviewer for the New England Journal of medicine, Annals of Internal Medicine, JAMA, Blood and several other high profile journals.

Board Certifications

FRCPC (Canada) Internal Medicine - 1985

FRCPC (Canada) Hematology - 1986

American Board of Internal Medicine - 1985

American Board of Internal Medicine - Hematology - 1986

Healthwise Knowledgebase Topics Reviewed

Deep Vein Thrombosis

Venography

Education

M.D.: University of Ottawa, 1978
Rotating Internship, York Finch General Hospital, Toronto - 1978-1979
Residency in Internal Medicine, National Defense Medical Center, Ottawa - 1981-1982
Residency in Internal Medicine, Women's College Hospital, Toronto - 1982-1983
Residency in Internal Medicine, Sunnybrook Medical Center, Toronto - 1983-1984
Residency in Hematology, University of Toronto - 1984-1986
Research Fellowship, Thrombosis, Canadian Heart Fdn., McMaster University -1986-1988

Academic Appointments

Director, Clinical Trials Group, Henderson Research Centre, McMaster University - 1997-2005
Deputy Chief of Medicine, Hamilton health Sciences Corporation, 1998-2002
Chair, Department of Medicine, McMaster University - 2001-2002
Assistant Professor, Department of Medicine, McMaster University - 1989-1993
Associate Professor, Department of Medicine, McMaster University - 1993-1998
Professor, Department of Medicine, McMaster University - 1998 - Present

Professional Affiliations

Canadian Medical Association
Ontario Medical Association

Selected Publications

  1. Chan WS, Spencer FA, Crowther M, Rodger M, Ramsay T, Ginsberg JS. (2009) Predicting deep venous thrombosis in pregnancy: out in "LEFT" field? Ann Intern Med151:85-92
  2. Kearon C, Julian JA, Kovacs MJ, Anderson DR, Wells P, McKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kasis J, Rodger M, Hambleton J, Gent M, Ginsberg JS for the ELATE Investigators (2008). Influence of thrompophilia on risk of recurrent venous thromboembolism while on warfarin: Results from a randomized trial. Blood. 112:4432-4436.
  3. Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman J, Muntz JE, Raskob GE, Clements ML, Hantel MS, Schnee JM, Caprini JA. (2009). Oral thrombin inhibitor dibigatran etexilate vs the North American enoxaparin regimen for the prevention of venous thromboembolism after knee replacement surgery: the RE-MOBILIZE trial. J. Anthrop. 24:1-9.
  4. Ginsberg JS. Drug Therapy: Management of venous thromboembolism. (1996) New England Journal of Medicine335(24):1816-1828.
  5. Kearon C, Ginsberg JS, Julian JA, Douketis J, Solymoss S, Ockelford P, Jackson S, Turpie AG, MacKinnon B, Hirsh J, Gent M, for the Fixed-dose heparin (FIDO) Investigators. (2006). Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism. JAMA 296:935-942.

Financial Disclosure

No financial report received from reviewer.

Last Updated: January 27, 2010

related physicians

related services

Bon Secours International| Sisters of Bon Secours USA| Bon Secours Health System

This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Privacy Policy. How this information was developed to help you make better health decisions.

© 1995-2010 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.